Advanced search

Authors whose works are in public domain in at least one jurisdiction

List of works by Katja Hatz

Baseline Optical Coherence Tomography Findings as Outcome Predictors after Switching from Ranibizumab to Aflibercept in Neovascular Age-Related Macular Degeneration following a Treat-and-Extend Regimen

scientific article published on 4 August 2017

Changing from a pro re nata treatment regimen to a treat and extend regimen with ranibizumab in neovascular age-related macular degeneration

scientific article published on 11 January 2016

Comparing ranibizumab monotherapy and combination with single photodynamic therapy in wet AMD: retreatment and morphologic results

scientific article published on 13 October 2016

Contrast sensitivity and binocular reading speed best correlating with near distance vision-related quality of life in bilateral nAMD

scientific article published on 22 September 2020

INTRAVITREAL AFLIBERCEPT IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION WITH LIMITED RESPONSE TO RANIBIZUMAB: A Treat-and-Extend Trial

scientific article published on 19 September 2016

Low-Energy Stereotactic Radiotherapy for Treatment of Exudative Age-Related Macular Degeneration in a Treat-and-Extend Regimen

scientific article published in February 2018

Microvascular abnormalities and long-term efficacy after stereotactic radiotherapy under continued intravitreal anti-VEGF treatment for neovascular AMD

scientific article published on 21 December 2020

Polypoidal choroidal vasculopathy in Caucasian patients with presumed neovascular age-related macular degeneration and poor ranibizumab response

scientific article published on November 18, 2013

Ranibizumab 0.5 mg treat-and-extend regimen for diabetic macular oedema: the RETAIN study

scientific article

Ranibizumab plus verteporfin photodynamic therapy in neovascular age-related macular degeneration: 12 months of retreatment and vision outcomes from a randomized study

scientific article published on 29 November 2014

Treat and Extend versus Pro Re Nata regimens of ranibizumab in neovascular age-related macular degeneration: a comparative 12 Month study

scientific article published on 24 March 2016